Molecular Biology of Cancer Flashcards
Cancer
Disease characterized by loss of regulation of the cell cycle, normal checkpoints are bypassed, allowing defective DNA replication and cell division, greater frequency of aneuploidy
Causes of cancer
Mutations lead to uncontrolled proliferation of cells, occur as a result of ionizing and UV radiation, chemicals, spontaneous errors during replication
Normal detection of mutations
Cell has mechanisms for detecting mutations and halting genetic processes until corrections are made, if the mutation is severe, the cell undergoes apoptosis
Uncontrollable growth
Mutated cells proliferate and develop further mutations, tumor becomes most dangerous when it gains the ability to invade surrounding tissues and proliferate in distant sites (metastasis)
Defects in DNA repair
BRCA-1,2, causes breast, ovarian, and prostate cancer, repair by homologous recombination
Differences between normal cells and malignant cells
Infinite proliferative capacity, anchorage independent, resistant to growth inhibition, resistant to apoptosis, show signs of de-differentiation, can be metastatic
Oncogenes
Result from gain-of-function mutations of growth-promoting genes, corresponding normal gene is a proto-oncogene
Tumor suppressor genes
Normal genes that encode growth-inhibiting products that become inactivated in cancer cells (loss-of-function), inhibition of growth-inhibiting activities results in unregulated cell growth
Varmus and Bishop
Hypothesized that cancer is caused by mutations in cellular genes (not viruses), many v-onc have been isolated from retroviruses, cellular proto-oncogenes (c-onc) have been found
Classes of cellular proto-oncogenes (c-onc)
Cellular growth factors, hormone and growth factor receptors, signal transduction proteins, GTP-binding proteins, nonreceptor protein kinases, transcription factors
Cell cycle
Activated by growth factors, hormone messengers, work through cyclins and cyclin-dependent kinases (CDKs), regulated by phosphorylation and cyclin-dependent kinase inhibitors (CKIs)
Conversion of proto-oncogene to oncogenes
Radiation or chemical mutagen, gene rearrangement- places proto-oncogene under control of strong transcriptional activator and fuses with with another protein, gene amplification
Mitogen activated protein kinase pathway
MAP kinase pathway activates transcription of myc and fos, phosphorylates AP-1 (fos and jun)
Ras
Monomeric G-protein in the cascade mediating cell growth/mitosis control by growth factors
Ras activation
Growth factors bind to receptors, relay signal to intracellular GTPases (like Ras), Ras becomes activated by binding GTP
Effect of stimulation of Ras
Stimulates phosphorylation cascade (MAP kinase cascade) that leads to activation of nuclear proteins that activate transcription, cell cycle is activated
Ras activation of the cell cycle
Mutations cause Ras to remain in active (GTP-bound) conformation leading to oncogenesis, Ras mutations are found in 20-25% of human tumors and up to 90% of specific tumor types
Neurofibromin (NF-1)
NF-1 activates Ras GTPase, NF-1 is a tumor suppressor, mutations in NF-1 cause neurofibromatosis
Retinoblastoma
Tumors from embryonic neural retina, occurs in young children, led to isolation of retinoblastoma suppressor gene Rb-1
Retinoblastoma protein (Rb)
Tumor suppressor product of the retinoblastoma gene, protein that functions as a negative regulator of cell cycle, arrests cells in G1 phase, halts cell proliferation